52

Gujarat Terce Laboratories LtdBOM 524314

Последний отчетный период 30 сент., 2023

Обновлено 20 сент., 2024

Последняя цена

Капитализация млрд. $

0.002

Micro

Биржа

XBOM - Bombay Stock Exchange

Анализ акций 524314.BO

52

Нет оценки

Количественный анализ Eyestock не покрывает акции Gujarat Terce Laboratories Ltd.

Капитализация млрд. $

0.002

Дивидендная доходность

Оборот

7.42 млрд

Сайт компании

https://www.gujaratterce.in/

Gujarat Terce Laboratories Ltd. engages in the manufacture and sale of pharmaceutical products. The company is headquartered in Ahmedabad, Gujarat. The firm is engaged in the development, manufacturing, marketing and distribution of medicines and healthcare products. Its diverse portfolio encompasses approximately 70 brands and 180 stock-keeping units (SKUs) covering multiple dosage forms, such as tablets, capsules, oral liquids, ointments and injectables. The firm offers therapies in areas of antibiotics, gynecology, respiratory, nutraceuticals, gastrointestinal and anti-fungal. The Company’s brands include Acolate, Codimol, Resplash, Terflora Z, Thyter, Tynol, Z-Oxi and Vitfol. The firm has approximately eight brands occupying a space in the top 10 in various therapeutic areas. The firm has a presence in over 13 states in India. The firm also has a presence in Eastern and Western Africa, the association of Southeast Asian Nations (ASEAN), and Latin American (LATAM) countries.

Смотреть Секцию: Рейтинг